Transcat Acquires Anmar Metrology, Inc.

Expands Life Science Market Presence in Southern California


ROCHESTER, N.Y., Aug. 24, 2015 (GLOBE NEWSWIRE) -- Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it has acquired, effective August 24, 2015, Anmar Metrology, Inc. ("Anmar "). Financial terms of the transaction were not disclosed.

Headquartered in San Diego, California, Anmar specializes in providing customized calibration and repair solutions for customers in multiple industries with a significant focus on the life science and defense market. Anmar is an ISO/IEC 17025 accredited provider with quality systems that conform to ISO 9001:2008 and ANSI/NCSL Z540 standards. Marty Bakker, President of Anmar, will remain with Transcat.

"The acquisition of Anmar is consistent with our strategy to strengthen our geographic coverage and enhance our current service platform in Southern California, a region rich in highly regulated life science and aerospace business," commented Lee D. Rudow, President and Chief Executive Officer of Transcat. "We will continue to benefit from Marty's leadership and welcome him and Anmar employees to the Transcat team.  They share our deep commitment to quality, accuracy and service and we look forward to working with them to grow the business."  

Marty Bakker, President of Anmar said, "In joining forces with Transcat, one of North America's leading calibration and compliance services providers, we greatly enhance our value proposition by offering customers in our market a broader suite of calibration, testing and validation services and products."

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration and compliance services, including analytical instrument qualifications, equipment and process validation. The Company is focused on providing best-in-class calibration analytics to highly regulated industries, particularly life science, including pharmaceuticals, medical device manufacturing and biotechnology. Transcat performs over 250,000 specialized technical services annually through a variety of delivery options, including permanent and periodic on-site services, mobile calibration services and in-house services (often accompanied by pick-up and delivery). The in-house services are offered through 20 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also answers the call with cGMP and GLP compliant services.

In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation, marketing more than 100,000 premier and proprietary brand instruments to approximately 22,000 customers.  

Transcat's growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found on its website at: Transcat.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions that often are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," and other similar words. All statements addressing operating performance, events, or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, sales operations, capital expenditures, growth strategy, potential acquisitions, customer preferences and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Transcat's Annual and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company's forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release.



            

Contact Data